e-ISSN: Pending
Negative / Null Result ReportOpen accessMedicine· cited by 10

Trajectories of plasma and CSF MTBR-tau243 and phosphorylated-tau species across the Alzheimer’s disease continuum

Lyduine Eisa Collij; Gemma Salvadó; Kanta Horie; Nicolas R. Barthélemy; Tobey J. Betthauser; Olof T. Strandberg; Ruben A Smith; Sebastian Palmqvist · 2026 · Nature Communications

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

To efficiently implement plasma and cerebrospinal fluid (CSF) biomarkers for staging and prognosis of Alzheimer disease (AD), we must understand their dynamics across disease progression. We analyzed participants from the Swedish BioFINDER-2 study with mass spectrometry measurements of plasma and CSF tau species, including eMTBR-tau243/MTBR-tau243 and phosphorylation occupancies (%p-tau). Disease duration was estimated using Aβ-PET and tau-PET with the SILA algorithm. Bootstrapped LOESS models showed that %p-tau217 changes earliest, increasing just before Aβ-PET positivity. Other p-tau species

Abstract by Lyduine Eisa Collij; Gemma Salvadó; Kanta Horie; Nicolas R. Barthélemy; Tobey J. Betthauser; Olof T. Strandberg; Ruben A Smith; Sebastian Palmqvist, Nature Communications (2026) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: OpenAlex · DOI 10.1038/s41467-026-71732-1